Skip to main content
. 2020 May 28;41(7):895–901. doi: 10.1038/s41401-020-0423-5

Fig. 1. NLG919@DEAP-DPPA-1 nanoparticles for cancer immunotherapy.

Fig. 1

a The antitumor mechanism of the multifunctional peptide in the tumor microenvironment. b Transmission electron microscopy images of nanoparticles under different pH conditions with or without recombinant human MMP-2 (rhMMP-2). Scale bars: 100 nm. c Treatment efficacy of peptide nanoparticles and the quantity of CD8+  T cells measured in melanoma-bearing mice. Copyright (2018), American Chemical Society.